Psychedelic drugs like psilocybin, LSD and MDMA have amazing medicinal and commercial potential. So does ketamine, but ketamine is already legal.
Psychedelics
Congressman Says He’ll Bring The Psychedelics Reform Movement To Capitol Hill ‘This Year’
A congressman said on Wednesday that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.”
PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease
PharmaTher initiates a Phase 2a clinical trial for a ketamine-based therapy for Parkinson's Disease, expected to commence in October 2021.
Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application
Optimi Health files a provisional patent application for a stable extraction method for natural psilocybin.
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson
Mydecine's lead drug candidate, MYCO-001 will be used in a major, new smoking cessation clinical study by Johns Hopkins.
Levitee Labs Publishes First Revenue Figures for August 2021
Levitee Labs reports (unaudited) revenues of CAD$893,863 for the month of August from clinic operations.
Seattle Becomes Largest U.S. City To Decriminalize Psychedelics
Seattle’s City Council approved a resolution Monday to decriminalize noncommercial activity around a wide range of psychedelic substances, including the cultivation and sharing of psilocybin mushrooms, ayahuasca, ibogaine and non-peyote-derived mescaline.
Psychedelics Regulation and Commercialization: Insights and Updates
The Schedule I classification for psychedelic drugs needs to be changed. But to what -- and when? Psychedelic Stock Watch takes a broad look at that question.
Mydecine Completes Spin-Out of U.S. Cannabis Assets
Mydecine spins out the company's cannabis assets into a private subsidiary, to comply with with the regulatory requirements of both the NASDAQ and London Stock Exchange.
California Could Decriminalize Drug “Magic Mushrooms” as Early as Next Year
The seeds have been planted for another California law that could loosen restrictions on the use of recreational drugs in the United States.
MINDCURE Announces Commencement of Trading on the OTCQX Best Market
MINDCURE announces its addition to the OTCQX Best Markets tier.
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
Novamind opens the 6th mental health clinic in its Cedar Psychiatry network, located in Murray, Utah. Novamind is now projecting a total of 65,000 clinic visits this year.
How The SAFETY Of Psychedelic Drugs Is Driving A Medical Revolution
Two billion people suffer from treatable mental health disorders resulting in 8 million preventable deaths per year. Psychedelics can address this catastrophe -- but first these drugs must be legalized.
Another Michigan City Advances Psychedelics Decriminalization Support
Yet another Michigan city has approved a resolution on Tuesday calling for decriminalization of a wide range of psychedelics such as psilocybin and ayahuasca.